Clinical Trial Update: Add-on Simvastatin in Schizophrenia Trial [NA]

View source ↗

Summary

This update reports on a trial testing add-on simvastatin for schizophrenia, sponsored by the New York State Psychiatric Institute. The trial status is TERMINAT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Schizophrenia | NA | Status: TERMINATED